DK429584A - Fremgangsmaade til fremstilling af carbapenemer - Google Patents

Fremgangsmaade til fremstilling af carbapenemer Download PDF

Info

Publication number
DK429584A
DK429584A DK429584A DK429584A DK429584A DK 429584 A DK429584 A DK 429584A DK 429584 A DK429584 A DK 429584A DK 429584 A DK429584 A DK 429584A DK 429584 A DK429584 A DK 429584A
Authority
DK
Denmark
Prior art keywords
carbapenems
procedure
manufacturing
manufacturing carbapenems
Prior art date
Application number
DK429584A
Other languages
English (en)
Other versions
DK429584D0 (da
Inventor
Pierre Dextraze
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK429584D0 publication Critical patent/DK429584D0/da
Publication of DK429584A publication Critical patent/DK429584A/da

Links

Classifications

    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L27/00Devices consisting of a plurality of semiconductor or other solid-state components formed in or on a common substrate
    • H01L27/02Devices consisting of a plurality of semiconductor or other solid-state components formed in or on a common substrate including semiconductor components specially adapted for rectifying, oscillating, amplifying or switching and having potential barriers; including integrated passive circuit elements having potential barriers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/061,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Power Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Computer Hardware Design (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK429584A 1983-09-09 1984-09-07 Fremgangsmaade til fremstilling af carbapenemer DK429584A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53001283A 1983-09-09 1983-09-09

Publications (2)

Publication Number Publication Date
DK429584D0 DK429584D0 (da) 1984-09-07
DK429584A true DK429584A (da) 1985-03-10

Family

ID=24112102

Family Applications (1)

Application Number Title Priority Date Filing Date
DK429584A DK429584A (da) 1983-09-09 1984-09-07 Fremgangsmaade til fremstilling af carbapenemer

Country Status (17)

Country Link
KR (1) KR870001743B1 (da)
AT (1) AT387387B (da)
CA (1) CA1273010A (da)
CS (1) CS248721B2 (da)
DD (1) DD232495A5 (da)
DK (1) DK429584A (da)
ES (1) ES535718A0 (da)
FI (1) FI843466A (da)
GR (1) GR80297B (da)
HU (1) HU192431B (da)
LU (1) LU85535A1 (da)
NO (1) NO843541L (da)
OA (1) OA07808A (da)
PT (1) PT79184B (da)
SU (1) SU1395142A3 (da)
YU (1) YU154884A (da)
ZW (1) ZW15184A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2945534B1 (fr) 2009-05-12 2012-11-16 Sanofi Aventis DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52147B1 (en) * 1980-03-27 1987-07-08 Merck & Co Inc 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation
EP0074599A1 (en) * 1981-09-09 1983-03-23 Takeda Chemical Industries, Ltd. 5,6-cis-Carbapenem derivatives, their production and use

Also Published As

Publication number Publication date
AT387387B (de) 1989-01-10
ES8601218A1 (es) 1985-11-01
GR80297B (en) 1985-01-09
FI843466A0 (fi) 1984-09-05
OA07808A (fr) 1986-11-20
KR870001743B1 (ko) 1987-09-26
ATA289784A (de) 1988-06-15
CA1273010A (en) 1990-08-21
FI843466A (fi) 1985-03-10
LU85535A1 (fr) 1985-04-29
SU1395142A3 (ru) 1988-05-07
HUT34979A (en) 1985-05-28
PT79184B (en) 1986-11-24
KR850002099A (ko) 1985-05-06
CS248721B2 (en) 1987-02-12
YU154884A (en) 1987-06-30
PT79184A (en) 1984-10-01
ZW15184A1 (en) 1985-04-03
ES535718A0 (es) 1985-11-01
DK429584D0 (da) 1984-09-07
HU192431B (en) 1987-06-29
NO843541L (no) 1985-03-11
DD232495A5 (de) 1986-01-29

Similar Documents

Publication Publication Date Title
DK33291A (da) Fremgangsmaade til fremstilling af en optisk komponent
DK382084A (da) Fremgangsmaade til fremstilling af penemer
DK162580C (da) Fremgangsmaade til fremstilling af mikrokapsler
DK166282C (da) Fremgangsmaade til fremstilling af cephemforbindelser
DK606084D0 (da) Fremgangsmaade til fremstilling af 2-fluor-17beta-oestradiol
DK386784D0 (da) Fremgangsmaade til fremstilling af alfa-6-desoxy-tetracykliner
DK445984D0 (da) Fremgangsmaade til fremstilling af cephalosporiner
DK294584D0 (da) Fremgangsmaade til fremstilling af formparter
DK87082A (da) Fremgangsmaade til fremstilling af cemnetklinker
DK304185A (da) Fremgangsmaade til fremstilling af furanon
DK37890A (da) Fremgangsmaade til fremstilling af 6-deoxyanthracycliner
DK132084A (da) Fremgangsmaade til fremstilling af mikrokapsler
DK299083D0 (da) Fremgangsmade til fremstilling af cephalosporinforbindelser
DK202983D0 (da) Fremgangsmade til fremstilling af l-lysin
DK429584A (da) Fremgangsmaade til fremstilling af carbapenemer
DK535083D0 (da) Fremgangsmade til fremstilling af cephalosporinforbindelser
DK161754C (da) Fremgangsmaade til fremstilling af en optisk komponent
DK156389C (da) Fremgangsmaade til fremstilling af nitromethan
DK614784A (da) Fremgangsmaade til fremstilling af koenroeg
DK65883D0 (da) Fremgangsmade til fremstilling af elastase
DK573184A (da) Fremgangsmaade til fremstilling af polyphenylenoxid
DK351883D0 (da) Fremgangsmade til fremstilling af nitromethan
DK575584D0 (da) Fremgangsmaade til fremstilling af polyphenylenoxid
DK235182A (da) Fremgangsmaade til fremstilling af chromgaer
DK371184A (da) Fremgangsmaade til fremstilling af polypropylenfibre

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment